Search is Powered by Google
Multiple Sclerosis News

MS Commissioning Pathway, UK

Main Category: Multiple Sclerosis
Article Date: 13 Nov 2008 - 2:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

The MS Trust is delighted that the new MS commissioning pathway has been made available via the Department of Health website. The MS Trust has launched the Pathway designed to simplify the process and enable commissioners to provide effective MS services.

Successful management of multiple sclerosis requires input from both specialist neurology staff within the secondary sector as well as ongoing support from the primary care teams. World class commissioning for MS is a noble aim, but requires knowledge of a complex process, which is not always readily available to primary care trusts and commissioners.

The MS Trust has therefore launched the MS Commissioning Pathway to simplify the process and enable commissioners to provide effective commissioning for MS. Produced in partnership with all the major organisations with MS expertise, and based in the 18-week software used by the Department of Health for other pathways, it provides information on the requirements for MS commissioning from diagnosis onwards.

The MS Commissioning Pathway includes red flags for critical assessment in the disease progression, identification points where the clock starts and stops to meet targets and indicates the links between primary, secondary and tertiary providers of care. Primary care trusts can localise the pathway to suit their specific requirements.

Commenting on the project Nicola Russell, Director of Services of the MS Trust said: "This Pathway has been produced following consultation with all the major parties and we are hopeful that it will be the key to successful commissioning in the future. We are especially grateful to the Royal College of Physicians, the Royal College of Nursing, Pathways for Health, commissioners, health professionals, and the MS Society for their help with its production."

MS Trust




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Urology
ADHD Autism Diabetes

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
MS Damage May Be Reversed By Leukemia Drug
23 Oct 2008
Researchers in the UK found that alemtuzumab, a drug initially developed to treat leukemia, stopped the advance of multiple sclerosis (MS) in patients with early stage active relapsing-remitting multiple sclerosis (RRMS)...


Talking with Your Doctor image Talking with Your Doctor

Talking with your doctor can sometimes be difficult. Good health care, however, depends on an open dialogue between patients and doctors...

An MS Drug Back on the Market image An MS Drug Back on the Market

After being suspended from the market for safety reasons, natalizumab is again available for the treatment of multiple sclerosis. Safeguards are in place because of a small risk in developing a serious brain infection. Should you consider taking this drug...

View more videos...